Cancer cells are hallmarked by high proliferation and imbalanced redox consumption and signaling. Various oncogenic pathways such as proliferation and evading cell death converge on redox-dependent ...

Sapanisertib is a dual mTORC 1/2 inhibitor that targets a key survival mechanism in KEAP1/NRF2-mutated tumor cells. The Food and Drug Administration (FDA) has granted Fast Track designation to ...

Skeletal muscle mass and function becomes progressively compromised with aging, chronic disease, and physical inactivity. Oxidative stress plays an important role in loss of skeletal muscle mass and ...

Alpha-fetoprotein up-regulated the expression of c-Src in hepatoma cells is PTEN/AKT signaling pathway dependent or independent. Background: We previously demonstrated that transcription factor Nrf2 ...

Evaluating interaction between tumor educated platelets and cancer stem cells on breast cancer subtypes. Multimodal analysis of methylation and fragmentomic profiles in plasma cell free DNA for ...

Vividion Therapeutics Inc. has disclosed VVD-065, a novel, first-in-class, allosteric molecular glue of the KEAP1-CUL3 E3-ligase complex, for the potential treatment of NRF2-activated cancers. NRF2 ...

C4XD will receive milestone payments worth up to $16m ahead of the first clinical trial C4XD will receive milestone payments worth up to $16m ahead of the first clinical trial C4XD – a company focused ...